Your browser doesn't support javascript.
loading
SleepWell24, a Smartphone Application to Promote Adherence to Positive Airway Pressure Therapy: Feasibility and Acceptability in a Randomized Controlled Trial.
Petrov, Megan E; Epstein, Dana R; Krahn, Lois; Todd, Michael; Park, John G; St Louis, Erik K; Morgenthaler, Timothy I; Hoffmann, Coles M; Hasanaj, Kristina; Hollingshead, Kevin; Yu, Tsung-Yen; Buman, Matthew P.
Afiliación
  • Petrov ME; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.
  • Epstein DR; College of Health Solutions, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, USA.
  • Krahn L; Center for Sleep Medicine, Department of Pulmonary Medicine, Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, USA.
  • Todd M; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.
  • Park JG; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • St Louis EK; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Departments of Neurology and Medicine, Mayo Clinic College of Medicine and Science, Rochester, La Crosse, WI, USA.
  • Morgenthaler TI; Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hoffmann CM; Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.
  • Hasanaj K; College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
  • Hollingshead K; College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
  • Yu TY; College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
  • Buman MP; College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
Behav Sleep Med ; : 1-13, 2023 Nov 30.
Article en En | MEDLINE | ID: mdl-38032115
OBJECTIVE: To investigate the feasibility and acceptability of SleepWell24, a multicomponent, evidence-based smartphone application, to improve positive airway pressure therapy (PAP) adherence, among patients with obstructive sleep apnea (OSA) naive to PAP. METHODS: In a single-blind randomized controlled trial, SleepWell24, with a companion activity monitor was compared to usual care plus the activity monitor and its associated app. SleepWell24 provides objective feedback on PAP usage and sleep/physical activity patterns, and chronic disease management. Patients were recruited from two sleep medicine centers and followed over the first 60 days of PAP. Feasibility and acceptability were measured by recruitment/retention rates, app usage, differences in post-trial Treatment Evaluation Questionnaire (TEQ) scores, and patient interviews. Exploratory, intent-to-treat logistic and linear mixed models estimated PAP adherence and clinical outcomes. RESULTS: Of 103 eligible participants, 87 were enrolled (SleepWell24 n = 40, control n = 47; mean 57.6y [SD = 12.3], 44.8% female). Retention was ≥95% across arms. There were no significant differences in TEQ scores. SleepWell24 participants engaged with the app on 62.9% of trial days. PAP use was high across both arms (SleepWell24 vs. Control: mean hours 5.98 vs. 5.86). There were no differences in PAP adherence or clinical outcomes. CONCLUSIONS: SleepWell24 was feasible and acceptable among PAP-naive patients with OSA. CLINICAL TRIAL REGISTRATION: NCT03156283https://www.clinicaltrials.gov/study/NCT03156283.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Behav Sleep Med Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA / PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Behav Sleep Med Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA / PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos